News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
PATTI JOSEPH M
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 04/15/2022 |
4
| PATTI JOSEPH M (Director) has filed a Form 4 on Armata Pharmaceuticals, Inc.|
Txns:
| Granted 33,000 options to buy
@ $5.11, valued at
$168.6k
|
|
| 06/09/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/09/2020 |
4
| PATTI JOSEPH M (Director) has filed a Form 4 on Armata Pharmaceuticals, Inc.|
Txns:
| Granted 23,000 options to buy
@ $3.15, valued at
$72.5k
|
|
| 05/24/2019 |
4
| PATTI JOSEPH M (Director) has filed a Form 4 on Armata Pharmaceuticals, Inc.|
Txns:
| Granted 27,383 options to buy
@ $3.15, valued at
$86.3k
|
|
| 05/16/2019 |
3
| PATTI JOSEPH M (Director) has filed a Form 3 on Armata Pharmaceuticals, Inc. |
| 04/05/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 08/12/2016 |
4
| PATTI JOSEPH M (CEO) has filed a Form 4 on Aviragen Therapeutics, Inc.|
Txns:
| Granted 380,000 options to buy
@ $1.3, valued at
$494k
|
|
| 09/28/2015 |
4
| PATTI JOSEPH M (CEO) has filed a Form 4 on Biota Pharmaceuticals, Inc.|
Txns:
| Bought 2,500 shares
@ $1.885, valued at
$4.7k
Bought 2,500 shares
@ $1.85, valued at
$4.6k
|
|
| 08/13/2015 |
4
| PATTI JOSEPH M (CEO) has filed a Form 4 on Biota Pharmaceuticals, Inc.|
Txns:
| Granted 250,000 options to buy
@ $2.49, valued at
$622.5k
|
|
| 03/31/2015 |
4
| PATTI JOSEPH M (CEO) has filed a Form 4 on Biota Pharmaceuticals, Inc.|
Txns:
| Bought 10,000 shares
@ $2.27, valued at
$22.7k
Bought 10,000 shares
@ $2.2989, valued at
$23k
|
|
| 10/02/2014 |
4
| PATTI JOSEPH M (CEO and President) has filed a Form 4 on Biota Pharmaceuticals, Inc.|
Txns:
| Granted 475,000 options to buy
@ $2.45, valued at
$1.2M
|
|
| 07/02/2014 |
4
| PATTI JOSEPH M (EVP, Corporate Dev & Strategy) has filed a Form 4 on Biota Pharmaceuticals, Inc.|
Txns:
| Bought 10,000 shares
@ $2.86, valued at
$28.6k
|
|
| 06/30/2014 |
4
| PATTI JOSEPH M (EVP, Corporate Dev & Strategy) has filed a Form 4 on Biota Pharmaceuticals, Inc.|
Txns:
| Bought 4,200 shares
@ $2.81, valued at
$11.8k
Bought 800 shares
@ $2.78, valued at
$2.2k
|
|
| 06/12/2014 |
4
| PATTI JOSEPH M (EVP, Corporate Dev & Strategy) has filed a Form 4 on Biota Pharmaceuticals, Inc.|
Txns:
| Bought 8,451 shares
@ $2.45, valued at
$20.7k
Bought 400 shares
@ $2.62, valued at
$1k
Bought 2,995 shares
@ $2.797, valued at
$8.4k
Bought 2,621 shares
@ $2.974, valued at
$7.8k
|
|
| 12/09/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 11/14/2012 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 11/14/2012 |
3
| PATTI JOSEPH M (EVP, Corporate Dev & Strategy) has filed a Form 3 on Biota Pharmaceuticals, Inc. |
| 11/08/2011 |
4
| PATTI JOSEPH M (Chief Scientific Officer) has filed a Form 4 on INHIBITEX, INC.|
Txns:
| Sold 174,596 shares
@ $7.79, valued at
$1.4M
Sold 35,000 shares
@ $8, valued at
$280k
Exercised (in-or-at-the-money) 35,000 options
@ $2.05, valued at
$71.8k
|
|
| 09/16/2011 |
4
| PATTI JOSEPH M (Chief Scientific Officer) has filed a Form 4 on INHIBITEX, INC.|
Txns:
| Granted 105,000 options to buy
@ $3.225, valued at
$338.6k
|
|
| 01/04/2011 |
4
| PATTI JOSEPH M (Chief Scientific Officer) has filed a Form 4 on INHIBITEX, INC.|
Txns:
| Exercised 12,606 shares
@ $2.64, valued at
$33.3k
Exercised 12,606 options to buy
@ $0.68, valued at
$8.6k
|
|
| 10/06/2010 |
4
| PATTI JOSEPH M (Chief Scientific Officer) has filed a Form 4 on INHIBITEX, INC.|
Txns:
| Granted 112,500 options to buy
@ $1.785, valued at
$200.8k
|
|
| 04/20/2010 |
4
| PATTI JOSEPH M (Chief Scientific Officer) has filed a Form 4 on INHIBITEX, INC.|
Txns:
| Exercised 22,655 shares
@ $1.67, valued at
$37.8k
Exercised 22,655 options to buy
@ $0.29, valued at
$6.6k
|
|
|
|